patent-reexamination Marketing Related Topics 
JD Supra Law
APRIL 28, 2023
To add further insight and visibility into these relatively new proceedings, the USPTO’s Trademark Decisions and Proceedings.
LexBlog IP
JANUARY 27, 2023
10,464,992 (“the ’992 patent”), assigned to Regeneron Pharmaceuticals, Inc. While the ’992 patent was included in the Complaint against Mylan, it is not one of the narrowed six patents Regeneron indicated it will pursue for expedited trial. Mylan Pharmaceuticals Inc. Regeneron Pharmaceuticals, Inc.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
LexBlog IP
AUGUST 22, 2023
According to the petition, the ’992 patent claims “encompass a formulation comprising the VEGF inhibitor protein, aflibercept, which Regeneron markets under the trade name EYLEA®, and three excipients that are commonly used to stabilize proteins like aflibercept: polysorbate 20, phosphate buffer, and sucrose.”
Fish & Richardson Trademark & Copyright Thoughts
SEPTEMBER 16, 2022
Information and statements” may include, among other items, information that “refutes, or is inconsistent with, a position that the applicant takes in” either “opposing an argument of unpatentability relied on by the Office” or “asserting an argument of patentability.”. the party has a duty to submit the information to the USPTO.”.
Fish & Richardson Trademark & Copyright Thoughts
MAY 5, 2021
McDonough is a principal in Fish’s Boston office and her practice emphasizes patent prosecution , portfolio management , reexamination, counseling , and due diligence in the computer software and electrical fields. I was a patent litigator at Fish before transitioning to patent prosecutor and that trial experience informs my work.
43(B)log
NOVEMBER 8, 2021
1125(a), common law unfair competition, and false patent marking. ThermoLife’s website also advertises its “Patented Nitrate Technology.” (DE ThermoLife claims to hold “19 Nitrate Related Patents,” “More Than 450 Valid Claims,” and “Patent Coverage in 26 Countries.” What about statements about the scope of patents?
LexBlog IP
SEPTEMBER 9, 2022
On July 29th, 2022, the current director of the United States Patent and Trademark Office (USPTO), Katherine Vidal, published a notice in the federal register regarding the duty of disclosure before the patent office. For reexamination proceedings, “each individual” associated with the patent owner has a duty of disclosure.
Expert insights. Personalized for you.
52 
Let's personalize your content